Literature DB >> 25739915

A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression.

Felipe Vences-Catalán1, Chiung-Chi Kuo, Yael Sagi, Homer Chen, Neta Kela-Madar, Menno C van Zelm, Jacques J M van Dongen, Shoshana Levy.   

Abstract

A homozygous mutation in a splice site of the CD81 gene was identified previously in a patient, as the cause in a case of common variable immune deficiency (CVID). CD19 expression is reduced in mice that lack CD81; however, B cells in this patient lacked completely CD19 surface expression. The mutation led to an absence of the CD81 protein on the cell surface and it was assumed that the CD81 protein was not produced. Here we demonstrate that a truncated human CD81 mutant (CD81mut) was actually produced, but retained intracellularly. We also demonstrate that the truncated CD81mut protein is in close proximity to the intracellularly sequestered CD19. However, this interaction does not enable normal CD19 maturation and surface expression. In addition, we show that specific domains of CD81 enable retrieval and trafficking of human CD19 to the cell surface. Finally, we demonstrate that surface expression of CD19 requires CD81, even in non-B cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739915     DOI: 10.1007/s10875-015-0148-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.

Authors:  T Miyazaki; U Müller; K S Campbell
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  The extracellular δ-domain is essential for the formation of CD81 tetraspanin webs.

Authors:  Yahya Homsi; Jan-Gero Schloetel; Konstanze D Scheffer; Thomas H Schmidt; Nicolas Destainville; Luise Florin; Thorsten Lang
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

4.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

5.  CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.

Authors:  K Kitadokoro; D Bordo; G Galli; R Petracca; F Falugi; S Abrignani; G Grandi; M Bolognesi
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

6.  Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Authors:  A Higginbottom; E R Quinn; C C Kuo; M Flint; L H Wilson; E Bianchi; A Nicosia; P N Monk; J A McKeating; S Levy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

8.  Novel mutations in a Japanese patient with CD19 deficiency.

Authors:  H Kanegane; K Agematsu; T Futatani; M M Sira; K Suga; T Sekiguchi; M C van Zelm; T Miyawaki
Journal:  Genes Immun       Date:  2007-09-20       Impact factor: 2.676

9.  TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.

Authors:  Emmanuel Dornier; Franck Coumailleau; Jean-François Ottavi; Julien Moretti; Claude Boucheix; Philippe Mauduit; François Schweisguth; Eric Rubinstein
Journal:  J Cell Biol       Date:  2012-10-22       Impact factor: 10.539

10.  The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.

Authors:  Vera Rocha-Perugini; Muriel Lavie; David Delgrange; Jonathan Canton; André Pillez; Julie Potel; Cécile Lecoeur; Eric Rubinstein; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  BMC Microbiol       Date:  2009-05-28       Impact factor: 3.605

View more
  10 in total

1.  High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.

Authors:  Suraya Elfrink; Charlotte M de Winde; Michiel van den Brand; Madeleine Berendsen; Margaretha G M Roemer; Frank Arnold; Luuk Janssen; Alie van der Schaaf; Erik Jansen; Patricia J T A Groenen; Astrid Eijkelenboom; Wendy Stevens; Corine J Hess; J Han van Krieken; Joost S P Vermaat; Arjen H G Cleven; Ruben A L de Groen; Viviana Neviani; Daphne de Jong; Sjoerd van Deventer; Blanca Scheijen; Annemiek B van Spriel
Journal:  Blood       Date:  2019-07-31       Impact factor: 22.113

2.  Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket.

Authors:  Brandon Zimmerman; Brendan Kelly; Brian J McMillan; Tom C M Seegar; Ron O Dror; Andrew C Kruse; Stephen C Blacklow
Journal:  Cell       Date:  2016-10-27       Impact factor: 41.582

3.  Cryo-EM structure of the B cell co-receptor CD19 bound to the tetraspanin CD81.

Authors:  Katherine J Susa; Shaun Rawson; Andrew C Kruse; Stephen C Blacklow
Journal:  Science       Date:  2021-01-15       Impact factor: 47.728

4.  Novel CD81 Mutations in a Chinese Patient Led to IgA Nephropathy and Impaired BCR Signaling.

Authors:  Lu Yang; Ping Liu; Hongqiang Du; Ran Chen; Bo Zhou; Yanan Li; Lina Zhou; Xiangli Wang; Cuihua Liu; Yuan Ding; Xuemei Tang; Yongwen Chen; Yunfei An; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2022-07-18       Impact factor: 8.542

5.  Differentiation stage of myeloma plasma cells: biological and clinical significance.

Authors:  B Paiva; N Puig; M T Cedena; B G de Jong; Y Ruiz; I Rapado; J Martinez-Lopez; L Cordon; D Alignani; J A Delgado; M C van Zelm; J J M Van Dongen; M Pascual; X Agirre; F Prosper; J I Martín-Subero; M-B Vidriales; N C Gutierrez; M T Hernandez; A Oriol; M A Echeveste; Y Gonzalez; S K Johnson; J Epstein; B Barlogie; G J Morgan; A Orfao; J Blade; M V Mateos; J J Lahuerta; J F San-Miguel
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

Review 6.  Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?

Authors:  Floriana Giorgio; Mariabeatrice Principi; Giuseppe Losurdo; Domenico Piscitelli; Andrea Iannone; Michele Barone; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo
Journal:  Nutrients       Date:  2015-09-08       Impact factor: 5.717

7.  CD81 is a novel immunotherapeutic target for B cell lymphoma.

Authors:  Felipe Vences-Catalán; Chiung-Chi Kuo; Ranjani Rajapaksa; Caroline Duault; Noemi Andor; Debra K Czerwinski; Ronald Levy; Shoshana Levy
Journal:  J Exp Med       Date:  2019-05-23       Impact factor: 14.307

8.  Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Chiung-Chi Kuo; Caitlyn L Miller; Anderson Lee; Vishnu C Ramani; Stefanie S Jeffrey; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

Review 9.  "Immune TOR-opathies," a Novel Disease Entity in Clinical Immunology.

Authors:  Sophie Jung; Laura Gámez-Díaz; Michele Proietti; Bodo Grimbacher
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

10.  c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma.

Authors:  Alessandra Di Bacco; Nizar J Bahlis; Nikhil C Munshi; Hervé Avet-Loiseau; Tamás Masszi; Luísa Viterbo; Ludek Pour; Peter Ganly; Michele Cavo; Christian Langer; Shaji K Kumar; S Vincent Rajkumar; Jonathan J Keats; Deborah Berg; Jianchang Lin; Bin Li; Sunita Badola; Lei Shen; Jacob Zhang; Dixie-Lee Esseltine; Katarina Luptakova; Helgi van de Velde; Paul G Richardson; Philippe Moreau
Journal:  Eur J Haematol       Date:  2020-04-15       Impact factor: 2.997

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.